Impact of clinical pharmacist's interventions on potential drug–Drug interactions in the cardiac care units of two university hospitals in Shiraz, South of Iran
Impact of clinical pharmacist's interventions on potential drug–Drug interactions in the cardiac care units of two university hospitals in Shiraz, South of Iran

Mojtaba Shafiekhani; Negin Moosavi; Dena Firouzabadi; Soha Namazi

Volume 8, Issue 3 , July 2019, , Pages 143-148

Abstract
   The main objective of this study aimed to assess drug–drug interactions (DDIs) in the cardiac care unit (CCU) and cardiac surgery units and the role of a clinical pharmacist ...  Read More
Impact of CYP2C19 polymorphisms on serum concentration of voriconazole in iranian hematological patients
Impact of CYP2C19 polymorphisms on serum concentration of voriconazole in iranian hematological patients

Sholeh Ebrahimpour; Soha Namazi; Mehdi Mohammadi; Mohsen Nikbakht; Molouk Hadjibabaie; Hamidreza Taghvaye Masoumi; Ardeshir Ghavamzadeh

Volume 6, Issue 3 , July 2017, , Pages 151-157

Abstract
   This study aimed to determine the portion of Iranian patients who attain therapeutic serum concentrations of voriconazole (VRCZ) following administration of fixed doses. In addition, ...  Read More
A comparison of five common drug–drug interaction software programs regarding accuracy and comprehensiveness
A comparison of five common drug–drug interaction software programs regarding accuracy and comprehensiveness

Raziyeh Kheshti; Mohammadsadegh Aalipour; Soha Namazi

Volume 5, Issue 4 , October 2016, , Pages 257-263

Abstract
   Drug–drug interactions (DDIs) can cause failure in treatment and adverse events. DDIs screening software is an important tool to aid clinicians in the detection and management ...  Read More